Presenter:

Megan Esch, MD, Geisinger - has nothing to disclose. 

Learning Objectives:

At the completion of this session the participant should be able to:

• Describe the inflammatory spectrum of multiple sclerosis
• Explain the role of early treatment in reducing the risk of disease relapse and progression
• Recognize the role of biomarkers in assessing clinical demyelinating activity
• Discuss considerations for discontinuing disease modifying therapy in multiple sclerosis patients